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Abstract.  Human umbilical vein endothelial cells at- 
tach and spread on laminin-coated substrates.  Affinity 
chromatography was used to identify the attachment 
receptor.  Fractionation of extracts from surface- 
iodinated endothelial cells on human laminin- 
Sepharose yielded a heterodimeric complex, the 
subunits of which migrated with molecular sizes corre- 
sponding to 160/120 kD and  160/140 kD under non- 
reducing and reducing conditions,  respectively. The 
purified receptor bound to laminin  and slightly less to 
fibronectin and type IV collagen in a radioreceptor as- 
say. This endothelial cell laminin receptor was 
classified as an t~zB, integrin because monoclonal and 
polyclonal antibodies directed against the ct2 and/3, 
subunits immunoprecipitated the receptor.  Cytofluoro- 
metric analysis arid immunoprecipitation showed that 
the ix2 subunit is an abundant integrin ~t subunit in the 
endothelial cells and that the ot subunits associated 
with laminin binding in other types of cells are ex- 
pressed in these cells only at low levels. The ,v~, 
integrin appears to be a  major receptor for laminin  in 
the endothelial cells, because an anti-ix2 monoclonal 
antibody inhibited the attachment of the endothelial 
cells to human laminin.  These results define a new 
role for the o~2 subunit in laminin binding and suggest 
that the ligand specificity of the tx2/3t integrin,  which 
is known as a collagen receptor in other types of cells, 
can be modulated by cell type-specific factors to in- 
clude laminin binding. 
HESIVE properties of endothelial  cells play an impor- 
tant  role in the maintenance  of the vessel wall in- 
tegrity and in diseases such as thrombosis and arte- 
riosclerosis (Gimbrone,  1986).  On the luminal  side these 
cells form a nonthrombogenic surface, whereas on the basal 
side they rest on a basement membrane to which they adhere. 
The endothelial  basement membrane contains laminin,  type 
IV collagen, type V collagen, and protcoglycans  (Madri et 
al., 1980; Palotie et al., 1983; Fujiwara et al., 1984; Siebold 
et al.,  1988;  for review  see T'tmpl, 1989).  Many of these 
basement membrane components mediate endothelial  cell 
adherence.  Laminin,  in particular is thought to be important 
in this regard (Form et al., 1986; Madri and Williams,  1983; 
Herbst et al.,  1988). 
Various types of cells have been shown to have laminin 
receptors that arc members of the integrin  family. Integrins 
are  heterodimeric  proteins  that  consist of an  c~  and  a 
subunit; each intcgrin  is, therefore,  defined by its subunits 
(Pytela et al., 1986; Buck and Horwitz, 1987; Hynes, 1987; 
Ruoslahti  and  Picrschbacher,  1987; Hemler et al.,  1987; 
Takada  et al.,  1987).  Intcgrins  o~3B~ (Wayner and Carter, 
1987; Takada et al.,  1988; Gehlsen et al.,  1988; Gehlsen et 
al., 1989) and ad3~ (Sonnenberg  et al., 1988), as well as an 
integrin  similar  to o~,13t (Tomaselli  et al.,  1988;  Ignatius 
and Reichardt,  1988) have each been implicated  as laminin 
receptors.  Endothelial  cells are known to express the ~B,, 
O[3/~1, and ot~,  integrins  (Albelda et al.,  1989; Conforti et 
al.,  1989; Giltay et al.,  1989). The as/~l integrin  is a fibro- 
nectin receptor (Argraves et al.,  1987); ot3~1 is known as a 
laminin,  fibronectin,  and collagen receptor (Wayner et al., 
1988); while t~2B, has previously been identified as a colla- 
gen  receptor in  platelets  and  in other  cells (Wayner  and 
Carter,  1987; Kunicki et al.,  1988; Staatz et al.,  1989). In 
addition,  endothelial cells also express the vitronectin  recep- 
tor (o~v/33) (Suzuki et al.,  1987; Cheresh,  1987). Endothelial 
cells attach to laminin through an integrin-mediated  mecha- 
nism;  that is suggested by the inhibition  of endothelial  cell 
attachment to laminin by an antibody directed against the/~ 
integrin subunit (Cheng, Y. E, C. Damsky, and R. H. Kram- 
er,  unpublished observations).  However,  endothelial  cells 
have also been suggested to interact  with laminin  through  a 
69-kD protein (Yarmariello-Brown et al., 1988) that is not an 
integrin. 
To characterize the endothelial  cell receptor for laminin, 
we have used affinity chromatography procedures similar to 
those applied to other types of cells (Pytela et al., 1985a,b; 
Gehlsen et al., 1988), as well as antibody probes. Our results 
show that the endothelial  cells bind laminln through an inte- 
grin composed of or2 and/~. Since the a2B, integrin in other 
types of cells binds only to collagens, this finding reveals cell 
type-specific functional  heterogeneity of the ot2/3, integrin. 
©  The Rockefeller University Press, 0021-9525/89/11/2455/8 $2.00 
The Journal of Cell Biology, Volume 109,  November 1989 2455-2462  2455 Materials and Methods 
Chemicals 
PMSF,  soybean trypsin inhibitor,  2-mercaptoethanol, BSA, Triton X-100, 
EDTA, and protein A-Sepharose were purchased from Sigma Chemical Co. 
(St. Louis,  MO). Fluorescein-conjugated  goat anti-mouse or anti-rat IgG 
and IgM were obtained from Tago Inc.  (Burliugame,  CA).  Rabbit anti- 
mouse IgG antiserum was obtained from Cappel Laboratories (Malvern, PA). 
125I-Na was  from Amersham Corp.  (Arlington Heights,  IL).  Molecular 
size markers were from Pharmacia Fine Chemicals (Piscataway, NJ); pre- 
stained size markers were from Betbesde Research Laboratories  (Gaithers- 
burg,  MD). 
The peptide GRGDSP (Pierschhacher and Ruoslahti,  1984) modeled af- 
ter the cell attachment  site in fibronectin  was synthesized by solid-phase syn- 
thesis in a pepfide synthesizer (Applied Biosystems Inc., Foster City, CA) 
and purified by ion exchange HPLC. Cell culture reagents were from Irvine 
Scientific  (Santa Aria, CA). 
Proteins 
Mouse type IV collagen and mouse laminin isolated from the Eugelbreth- 
Holm-Swarm  murine tumor were  from Bothesda Research Laboratories, 
bovine type I collagen from Collaborative Research (Lexington,  MA), and 
human type I and type IV collagens were from Telios Pharmaceuticals (La 
Jolla, CA). Vitronectin was purified by monoclonai antibody affinity chro- 
matography  (Hayman et al.,  1983). Pepsin-extracted  laminin was isolated 
from human placental tissue by using monoclonai antibody affinity chroma- 
tography as described (Wewer et al.,  1983; Engvall et al.,  1986). In some 
experiments,  the human laminin preparations were further fractionated  by 
FPLC  on a  Mono Q  column (Pharmacia Fine Chemicals) as described 
(Dillner et al.,  1988).  Human plasma fibronectin was purified  by affinity 
chromatography  on gelatin-Sepharose  (Engvall and Ruoslahti,  1977). 
Antibodies 
Mouse monocloual antibody 2E8 has been described (Engvail et al., 1986). 
Mouse monocional anti ~t  antibody LM442  was  prepared against the 
fibronectin receptor purified from placenta in collaboration with Dr. David 
Cheresh, Department of Immunology,  Research Institute of Scripps Clinic. 
Mouse monoclonal antibodies A1A5, against the ~1 integrin subunit, and 
TS2/7,  against the cq  subunit, were obtained from Dr.  Martin Hemler 
(Dana-Farber Cancer Institute, Boston, MA). Monoclonai antibody AP3 to 
the ~3 subunit was obtained from Dr.  Tom Kunicki  (The Blood Center, 
Milwaukee,  WI). Mouse monoclonal antibodies to the or2 subunit (PIH5 
and P4B4), the c, subunit (P4G9) and the intagrin complexes c~3~1 (PIB5), 
and the c~5/~j (PID6) have been described (Wayner and Carter,  1987; Way- 
net et al., 1988; Wayner et al., 1989). PlH5 and P1D6 inhibit fibroblast and 
platelet adhesion to collagen- and fibronectin-coated  substrates, respectively 
(Kunicki et al., 1988; Wayner et al.,  1988). A monoclonal antibody P4H9 
to the/~2 (CDI8) integrin subunit was also used.  Rat monoclonal antibody 
GoH3 against the c~ integrin subunit was obtained from Dr. Arnund Son- 
nenberg (Netherlands Red Cross Blood Transfusion Service, Amsterdam, 
The Netherlands). For some experiments IgG was purified from culture su- 
pernatants on protein A-Sepharose as described (Ey et al.,  1976). 
Rabbit antisera against the human placental fibronectin receptor have 
been described (Pytela et al., 1987). Rabbit antisera prepared against pep- 
tides from the cytoplasmic  domains of the cc3 and ors subunits were ob- 
tained  from  Drs.  Eugene  Marcantonio  and  Richard  O.  Hynes  (Mas- 
sachusetts  Institute of Technology, Boston, MA) (Plantefaber and Hynes, 
1989;  Hynes et al.,  1989).  Rabbit anti or2 antiserum was  from Dr.  M. 
Hender (Dana Farber Cancer Institute, Boston, MA) ('Ihkada and Hemler, 
1989). Rabbit antiserum against human laminin has been described (V~'-wer 
et al.,  1983). 
Cells 
Endothelial cells were isolated  from human umbilical cords and cultured 
as described previously  (Languino et al.,  1989). The cells were used be- 
tween the 1st and lOth passages.  Some of the cell adhesion assays and the 
flow cytometric  analyses  were performed with human umbilical cord en- 
dothelial cells obtained from Cell Systems (Seattle, WA). Cells from each 
source were characterized as endothelial cells based on their cobblestone 
morphology and their expression of FVlll-associated antigen (Hoyer et al., 
1973). 
MG-63 human osteosarcoma cells were obtained from the American 
Type Culture Collection (Reckville,  MD) and grown in MEM with 10% 
FBS. 
Flow Cytofluorometric  Analysis of  Receptor 
Expression 
Expression of intagrin c~ and/~ subunits on endothelial cells was quantitatad 
by flow cytometry  on an EPICS 752 dual laser cell sorter (Coulter Elec- 
tronics,  Inc., Hialeah, FL) with an MDADS II data processor.  Relative 
fluorescence  intensity 0ug  fluorescence  intensity) was determined on a 
three-cycle log scale. Fluorescence histograms were derived by plotting cell 
number (y axis) as a function of log fluorescence  intensity (x axis) from 0 
to 255 (channel number). Background fluorescence  was determined with a 
nonimmune mouse IgG control. 
Endothelial cells incubated in Hanks' balanced salt solution (HBSS) sup- 
plemented with 20/~g/rnl purified goat IgG, 2 % BSA, and 0.02 % sodium 
azide for 30 rain at 40C to block Fc receptors.  The cells (2 ×  105/ml) were 
washed and incubated with the primary antibodies (10/~g/ml) in HBSS/SO- 
dium azide for 60 rain at 4°C. Then they were washed twice and incubated 
with FITC-conjugated goat anti-mouse (1:250 dilution) or F1TC-conjugated 
goat anti-rat (for GoH3) antibodies (1:100 dilution)  for 60 rain at 4°C. At 
the end of this incubation the cells were washed once, fixed in cold 2% 
paraformaldehyde,  and analyzed on the flow cytometer. 
Endothelial Cell Adhesion Assay 
Endothelial cell attachment to protein-coated substrates was measured in a 
cell adhesion assay  as described (Ruoslnhti  et al.,  1982).  The coating 
efficiencies for the extracellular  matrix proteins used in the assay have been 
shown to be similar (Dlllner et al.,  1988; Hautanon et al.,  1989). The en- 
dothelial cells for these assays were detached from culture flasks with 0.08 % 
trypsin and 0.2 raM EDTA in PBS. In antibody inhibition  experimems cells 
were incubated in MEM supplemented with (a) 1% BSA, and (b) various 
dilutions of the antiserum, prehnmune rabbit serum, or hybridoma culture 
media containing monocloual antibodies or IgGs purified from culture su- 
pernatants, for 1 h at 4°C, and then transferred to the adhesion assay. 
Nonadherent cells were removed after 2 h by washing with PBS and at- 
tached cells were fixed with 3 % paraformaldehyde  followed by staining with 
crystal violet. The attached cells were then dissolved in 1% SDS and the 
relative number of cells in each well was evaluated measuring the absor- 
bance at 600 nm in a Multiscan ELISA  reader (Flow Laboratories Inc., 
McLean, VA). 
Alternatively,  endothelial cells were labeled with Na2 51CrO4 (50 ttCi/ 
ml) for 4 h, washed,  and allowed to adhere to the substrates  as described 
(Wayner and Carter,  1987).  Attached cells were dissolved  in SDS/NaOH 
and radioactivity  was quantitated  in a gamma counter. 
A~finity Chromatography 
Human iaminin-Sepharose and  ll0-kD fibronectin fragment-Sepharose 
affinity matrices were prepared and used for receptor isolation as described 
previously (Pytela  et al.,  1985a,  1987; Gehlsen et al.,  1988;  Gailit and 
Rnoslahti,  1988). 
Electrophoresis 
Proteins were boiled in 3% SDS (wt/vol),  10% glycerol,  0.001% bromo- 
phenol blue, and 50 mM Tris-HC1,  pH 6.8, with or without added 5 % 
2-mercaptoethanoi.  The samples were run on a 7.5% polyacrylamide  gel 
in SDS (Laemmli, 1970) and the protein bands were visualized by Coomas- 
sie blue staining or by autoradiography. 
Radioreceptor  Assay 
The binding of receptors to various protein ligands was examined in a radio- 
receptor assay as previously described (Hautanen et al.,  1989). Microtiter 
wells  were  coated with 2  ttg/ml of the proteins examined.  The coating 
efficiency for various proteins has been previously shown to be ,,060  % under 
the conditions used (Dillner et al.,  1988;  Hautanen et al.,  1989).  125I- 
labeled laminin receptors isolated from surface-iodinated  cells were allowed 
to bind to the coated wells for 2 h in TBS (150 mM NaCI, 50 mM Tris-HC1, 
pH 7.5) containing 50 mM octyl-/~-glucopyranoside,  I mM PMSF,  1 mM 
CaC12, MgCl2,  with or without 1 mM MnCI2.  The amount of receptor 
bound to the wells was measured after solubilization in 1% SDS in TBS by 
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radioactivity. 
Immunoprecipitation 
Endothelial cells or MG-63 cells were surface labeled and proteins were im- 
munoprecipitated as described (Wayner and Carter,  1987); the buffer used 
for the immunoprecipitation contained 50 mM  Tris-HCl (pH 7.5),  I told 
PMSF, 1 mM CaCl2,  1 mM MgCI2, and 0.5% Triton X-100 (voi/vol). Iodi- 
hated receptors were immunoprecipitated using the same buffer but with 50 
mM octyl-B-glucopyranoside instead of Triton X-100. 
Results 
Laminin Promotes Endothelial Cell Adhesion 
Pepsin-extracted human  laminin  and mouse laminin  pro- 
moted endothelial cell adhesion to a similar extent (Fig.  I). 
Both laminin preparations were somewhat less active than 
fibronectin. Moreover, as observed earlier for other types of 
cells (Dillner et al., 1988), the cell morphology was different 
on these substrates; the cells appeared more elongated on the 
laminin-coated substratum than on fibronectin (not shown). 
A  further difference between the fibronectin and laminin- 
induced attachment was that the cell attachment-promoting 
peptide, GRGDSP, inhibited the attachment of the endothe- 
lial ceils to fibronectin by 90% at a concentration of 1 mg/ml 
but affected only marginally (19%  inhibition) their attach- 
ment to human laminin. 
Polyclonal  antilaminin  antibodies  inhibited  endothelial 
cell attachment to laminin but not to type IV collagen or 
fibronectin (Fig.  2).  Preimmune rabbit serum used at the 
same dilutions as the antilaminin did not inhibit the attach- 
ment of the cells to any of these ligands. These results show 
that the pepsin-extracted human  laminin  specifically pro- 
motes the attachment of endothelial cells. We next used this 
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Figure 1. Endothelial cell adhesion  to human laminia, mouse lami- 
nin, and fibronectin. Endothelial cells were trypsinized and allowed 
to adhere for 2 h to mierotiter wells coated with increasing concen- 
trations of pepsin-extracted human laminin that had been FPLC 
purified (e), mouse laminin (A), and human fibronectin (o). BSA 
coated wells (0) were used as a control. Attached cells were fixed 
and stained, and the number of cells attached were recorded using 
a multiscan ELISA reader after staining the cells with crystal violet. 
I  •  0  0  [] 
100  • 
c "I 
E 
so 
t  [  I  I  I  I 
1:1000  1  :t 00  1:10 
anti-laminin 
Figure 2. Inhibition of endothelial cell adhesion to laminin by an- 
tilaminin polyclonal antibodies. Cells were allowed to adhere to 
pepsin-extracted human laminin (e), human fibroncctin (o), and 
human type IV collagen (rT) in the presence  of various dilutions of 
the polyclonal antibody prepared against pepsin-extracted  human 
laminin. Coating concentrations were 5/~g/ml for laminin and type 
IV collagen, and 1 #g/ml for fibroncctin. The assay  was performed 
as in Fig.  I. 
laminin to identify laminin receptors by affinity chromatog- 
raphy. 
AJ~inity Chromatography  of Endothelial Cell Extracts 
on Human Laminin 
Affinity chromatography was performed by applying extracts 
from surface iodinated endothelial cells to laminin-Sepha- 
rose. Since integrin-type receptors bind to their ligands in a 
divalent cation--dependent manner (e.g.,  Gailit and Ruos- 
lahti, 1988) and since the attachment of endothelial cells to 
human larninin was inhibited by EDTA (result not shown), 
EDTA was used to elute the proteins bound to the affinity ma- 
trix. This procedure yielded an apparent integrin type recep- 
tor with an a  and a/3 subunit (Fig. 3). This integrin showed 
two bands of 160 and  140 kD under reducing conditions, 
while the fibronectin receptor, purified on ll0-kD fibronec- 
tin-Sepharose affinity matrix from the same cells and shown 
for comparison in lanes 2 of Fig. 3, had the previously ob- 
served mobility of 140 kD, Under nonreducing conditions, 
the laminin-binding integrin and fibronectin receptor sub- 
units migrated with the same approximate mobilities (160 
and 120 kD). In some preparations of the laminin-binding 
integrin, the intensity of labeling in the u  subunit was low, 
suggesting that the availability of this subunit for iodination 
on the endothelial cell surface may vary. 
The Endothelial Cell Laminin-binding Integrin Is the 
~213~ Integrin 
Polyclonal and monoclonal antibodies against integrins were 
used  to  identify  the  subunits  of  the  endothelial  cell  laminin- 
binding  intcgrin.  The  purified  integrin  bound to  a  polyclonal 
antibody that reacts with both the a  (as) and B (B,) subunits 
of the placental fibronectin receptor (Fig. 4, lane/). It also 
bound to monoclonal antibody PIH5, directed against the 
or2 subunit (Fig. 4, lane 8), to monoelonal antibody LM442 
directed against the t, subunit (Fig. 4, lane 12) that reacts 
also with the endothelial cell fibronectin receptor (Fig. 4, 
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of endothelial cell laminin-bind- 
ing  integrin.  Surface-iodinated 
endothelial cells  were fraction- 
ated on a laminin-Sepharose or a 
ll0-kD  fibronectin fragment- 
Sepharose column, and the col- 
umns were eluted with 20 mM 
EDTA. The peak fractions from 
each fraetionation were analyzed 
on a 7.5% acrylamide gel in SDS 
under  reducing (R)  and  nonre- 
ducing (NR) conditions. The la- 
minin-binding integrin (lanes 1) 
and fibronectin  receptor (lanes 2) 
subunits were visualized by auto- 
radiography.  The positions  of mo- 
lecular  size markers in kD are 
shown. 
lane 13) and to a polyclonal antibody prepared against the 
platelet Ot  2  subunit (not shown).  A  variable amount of an 
80-kD band was immunoprecipitated with the receptor;  it 
may be a degradation product of either of the receptor sub- 
units. 
Exhaustive imrnunoprecipitations with the anti-a2 poly- 
clonal antibody and with the LM442 anti-Bl  monoclonal 
antibody cleared all the material reactive with the antifibro- 
Figure 4.  Immunoprecipitation of laminin-binding integrins pu- 
rified from endothelial cells and MG-63 cells. The laminin-binding 
integrins purified by laminin-Sepharose affinity chromatography 
from surface-iodinated  endothelial cells (lanes 1, 4, 5, 6, 8, 10, and 
12) or MG-63 cells (2, 3, 7, 9, and 11), and fibronectin receptor 
purified by chromatography  on ll0-kD fibronectin  fragment-Seph- 
arose from endothelial ceils (lane 13), were immunoprecipitated 
with antibodies against integrins. The antibodies were polyclonal 
antifibronectin  receptor antibody (lanes I and 2), a polyclonal  anti- 
body against the or3 cytoplasmic domain (lanes 3 and 4), a poly- 
clonal antibody against the or5 cytoplasmic domain (lane 5),  a 
mouse anti-oe2 monoclonal antibody (P1H5) (lanes 8 and 9), and a 
mouse anti-B~ monoclonal antibody (LM442) (lanes 12 and 13). 
Nonimmtme rabbit serum (lanes 6 and  7) and 2E8 antilaminin 
monoclonal antibody (lanes 10 and//) were used as controls. A 
positive control for the anti-ors antibody is shown in Fig. 7. The 
immunoprecipitates were analyzed on a 7.5% SDS-PAGE under 
nonreducing condition and visualized by autoradiography.  The po- 
sitions of prestained marker proteins in kilodaltons are shown. 
nectin receptor antiserum, showing that the ¢2Bt integrin is 
the only significant component among the proteins obtained 
by  the  affinity chromatography on  laminin  (not  shown). 
Moreover, the PIH5 antibody (anti-a9 immunoprecipitated 
from surface-labeled endothelial cells two polypeptides with 
mobilities identical to those seen in the laminin bound prepa- 
ration  (not  shown).  The  endothelial cell  laminin-binding 
integrin did not react with polyclonal antibodies prepared 
against the cytoplasmic domains of the ~3 (Fig. 4,  lane 4) 
or oe5 (Fig. 4, lane 5) subunits, nor did it immunoprecipitate 
with monoclonal antibodies against o~3B~ or o~tB, integrin 
complexes (not shown). 
A laminin receptor isolated from the human MG-63 os- 
teosarcoma  cells  was  used  for  comparison  in  the  im- 
munoprecipitations. The MG-63 cell laminin receptor was 
also immunoprecipitated by the antifibronectin receptor an- 
tiserum (Fig. 4, lane 2). However, unlike the endothelial cell 
laminin-binding  integrin,  it  reacted  with  the  antiserum 
directed against the cytoplasmic domain of the ~3  subunit 
(Fig. 4,  lane 3) but not with the anti-a2 monoclonal anti- 
body PIH5 (Fig. 4,  lane 9). 
Taken together, these results show that the endothelial cell 
laminin-binding integrin is a heterodimeric molecule con- 
sisting of an ~  subunit antigenically indistinguishable from 
the or2 subunit, and a/~ subunit antigenically indistinguish- 
able from the integrin/3~ subunit. The results also show that 
the endothelial cell laminin-binding integrin is different from 
the MG-63 osteosarcoma cell laminin receptor. 
Binding Specificity of the Endothelial Cell 
Laminin-binding lntegrin 
The interaction of the purified laminin-binding integrin with 
laminin and other potential ligands was evaluated in a radio- 
receptor assay.  In the presence of Mn  2÷, the laminin-bind- 
ing integrin bound to human laminin, fibronectin, and hu- 
man type IV collagen in a concentration-dependent manner 
(Fig. 5). Saturation could not be studied, because the amounts 
of the laminin-binding integrin available became a limiting 
factor.  Assays performed in the presence of Ca  ~÷ and Mg  2÷ 
without Mn  ~+, showed similar specificity except that in the 
absence of Mn  z~ the iaminin binding was consistently high- 
er than the binding to fibronectin or type IV collagen. The 
integrin also interacted slightly with bovine type I collagen 
(22 % of the laminin binding) as well as with human type I 
collagen. The fibronectin receptor isolated from endothelial 
cells showed significant binding only to fibronectin among 
these proteins in the radioreceptor assay (not shown). 
To exclude the possibility that contaminants in the laminin 
preparation could be responsible for the observed laminin 
binding by the isolated integrin, we compared the binding of 
this integrin to different laminin preparations. There was no 
significant difference in the binding of this integrin to human 
laminin before (100%)  or after (90%) FPLC purification, 
and it also bound well to mouse laminin (90%). 
These  results  confirm the  ability of the  purified  ot2B~- 
related integrin to bind laminin to show that it can also bind 
to fibronectin, type IV collagen, and possibly type I col- 
lagen. 
Expression of lntegrin Subunits by Endothelial Cells 
The integrin surface phenotype of endothelial cells was de- 
termined by flow cytometry (Fig. 6). High levels of a,, a2, 
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Figure 5. Binding of endothelial cell laminin-binding integrin to ex- 
tracellular matrix proteins in radioreceptor assay. Microtiter wells 
were coated with pepsin-extracted human laminin (LM), human 
plasma/fibronectin (FN), human type IV collagen (TYPE/V),  or 
BSA, and the binding of the larninin-binding integrin isolated from 
surface-iodinated endothelial cells to the wells was assayed. Values 
are the mean of duplicate observations. 
and  c~5 were found,  a3 was present at low  levels,  while ct~ 
and  or6  were  present  at  trace  levels  (a6)  or  undetectable 
(or4). ~t, and 83 were expressed at high levels and no ~2 was 
detected  by flow cytometry. 
Immunoprecipitation  of detergent  extracts  from surface- 
labeled  endothelial  cells  confirmed  the  flow  cytometry 
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Figure 6. Expression of the integrin a  and ~i subunits on cultured 
endothelial cells. Endothelial cells were stained in suspension for 
the presence of six a  and three ~ subunits with the monoclonal anti- 
bodies TS2/7 (a0,  P1H5 (a2), PIB5 (a3), P4G9 (oa), P1D6 (as), 
GoH3 (a6), AlAS (~0, P4H9 (/32), and AP3 (/~3), and analyzed by 
flow cytometry. The results are expressed as histograms with cell 
number (y axis) plotted as a function of relative fluorescence inten- 
sity (x axis) as determined on a thre~-cycle log scale. The fluores- 
cence intensity is expressed in arbitrary units.  Background fluores- 
cence with nonimmune mouse IgO control is also shown (BKG). 
Figure 7. Electrophomic anal- 
ysis of the integrins expressed 
on  endothelial  cell  surface. 
Detergent extracts of surface- 
iodinated  endothelial  cells 
were  immunoprccipitated  with 
a  polyclonal  antibody  against 
a5 cytoplasmic  domain (lane 
I  )  or  mouse  monoclonal  anti- 
a3  (PIB5),  anti-a6  (GoH3), 
and anti-a2 (P4B4)  antibodies 
(lanes  2,  3,  and  4,  respec- 
tively).  The  immunoprecipi- 
rates were run on Z5%  SDS- 
PAGE in the presem~e  of  2-rner- 
captoethanol  and  visualized 
by autoradiography. 
results  (Fig.  7). Among  the potential  laminin receptor  a 
subunits,  high levels  of  c~j were observed (Fig.  7,  lane  4) 
whereas a3~,  (Fig.  7,  lane  2)  and a~  (Fig.  7,  lane  3)  were 
very low or undctectable.  Also in  agreement with the  flow 
cytometry results,  high levels of asfl~  were detected by im- 
munoprecipitation with an as-specific antibody (Fig. 7, lane 
/). Taken together,  these  data  show that  a2~  is a major 
integrin expressed by human  umbilical vein endothelial 
cells. 
Role of ,~2~1 Integrin in Endothelial Cell Adhesion to 
Laminin 
To evaluate the contribution  of the  a2fll  integfin  in the at- 
tachment of the endothelial cells to laminin, we assayed vari- 
ous  monoclonal  antibodies  for their  ability  to  inhibit  this 
attachment.  The  P1H5  monoclonal  antibody,  which  is  an 
anti-a2,  inhibited  endothelial  cell adhesion to human lami- 
nin by up to 80%  (Fig. 8). Inhibitory monoclonal antibodies 
to a3 and a5 (P1B5 and P1D6) had no effect, but an inhibi- 
tory  antibody  against  a6  (GoH3)  partially  inhibited  the 
laminin attachment.  However, as shown above (Figs.  6  and 
7), the endothelial cells expressed only small amounts of this 
potential laminin receptor, and the purified laminin-binding 
integrin  was  not  immunoprecipitated  by  the  anti-a6  anti- 
body.  Therefore,  if the  a6~l  integfin  plays  a  role  in  the 
laminin attachment of endothelial cells, such a role is likely 
to be only a minor one under the conditions we have exam- 
Languino et al. Endothelial Cell Laminin Receptor  2459 150 
100 
N  5G 
l  I  [  [  I  l 
0.1  1  10 
ami-% (~g/ml) 
Figure 8.  Inhibition of endothelial cell adhesion to laminin by 
monoclonal anti ix2. Endothelial cells (6 x  103 cells/well) were al- 
lowed to adhere to microtiter wells coated with pepsin-extracted  hu- 
man laminin (*, 5/tg/ml), fibronectin (o, 1/~g/ml), or vitronectin 
(zx,  3 pg/ml),  in the  presence of increasing concentrations of 
purified anti a2-monoclonal  antibody P1HS, and the number of ad- 
herent cells was quantitated  as in Fig. 1. Values are means of dupli- 
cates. 
ined. Controls showed that the PIH5 antibody did not affect 
endothelial cell attachment to fibronectin or vitronectin even 
at the highest concentrations used (Fig. 8).  However,  it did 
inhibit their adhesion to type I collagen by 90% at a concen- 
tration of 10  ag/rni.  MG-63  cell attachment to  laminin, 
which is mediated by an <x3 integrin (Gehisen et al.,  1988; 
Gehlsen et al.,  1989)  was not inhibited by PIHS. 
Discussion 
The results reported here show that a laminin receptor from 
human umbilical vein endothelial cells is immunologically 
indistinguishable from the cx~ integrin. This is a surpris- 
ing finding for several reasons: the ~2/~ integrin has previ- 
ously been identified as a  collagen receptor (Wayner and 
Carter,  1987; Kunicki et al.,  1988),  three other integrins 
have been found to function as laminin receptors in other 
cells (Ignatius and Reichardt,  1988;  Gehlsen et al.,  1988; 
Sonnenberg, 1988; Gehlsen et al., 1989), and the endothelial 
cell laminin receptor has been reported to be a 69-kD protein 
unrelated to integrins (Yannariello-Brown et al.,  1988). 
The role of the a,/~, integrin as a laminin receptor in en- 
dothelial cells  is  supported by a  number of observations 
reported here. First, chromatography of endothelial cell ex- 
tracts on a laminin matrix yielded an integrin that was essen- 
tially quantitatively immunoprecipitable with monoclonal 
antibodies directed against the ~2 or the Bt  subunit.  Sec- 
ondly, the isolated receptor bound to both human and mouse 
laminins in a  radioreceptor assay.  Thirdly, a  monoclonal 
anti-c~2 antibody  inhibited  the  attachment  of endothelial 
cells to laminin. These results show that the endothelial cells 
express a laminin receptor that is an integrin not previously 
associated with laminin binding, and they therefore define a 
new role for the ot2B, integrin, in addition to its previously 
known role as a collagen receptor. 
The tx2/3j integrin has been considered a collagen recep- 
tor because (a) functional antibodies directed against the or2 
subunit inhibit the binding of cells to collagen (Wayner and 
Carter,  1987) and (b) the a2flJ integrin isolated from plate- 
lets binds to various types of collagens but has no affinity for 
laminin (Staatz et al., 1989). In fact, the laminin receptor of 
platelets is reported to be the <x~Ba integrin (Sounenberg et 
al., 1988). In contrast to the platelet tx2fl, integrin, the inte- 
grin we have isolated from endothelial cells binds to laminin 
and, somewhat tess efficiently, to collagens and fibronectin. 
The molecular basis of the apparent specificity difference 
among the a2fl,  integrins is unclear.  The endothelial cell 
receptor subunits reacted with each of the monoclonal and 
sequence-specific polyclonal anti-ere and anti-/~, antibodies 
we tested. This result argues for extensive similarity of the 
endothelial cell 0~2~l  integrin with ct2/~, integrin from other 
cells. This similarity raises the exciting possibility that the 
already impressive diversity of the integrin system could be 
further augmented by cell type regulation of the specificities 
of individual integrins. Possible molecular mechanisms for 
such regulation include alternative mRNA splicing, post- 
translational modification of the receptor, or the association 
of the receptor with some modifying component that differs 
among different cell types. One alternative splicing for inte- 
grin subunits has already been found (van Kuppevelt et al., 
1989), and gangliosides would be candidates for modulating 
factors, since they are known to be associated with integrins 
(Cheresh et al.,  1987). 
The ae-contaiaing integrin we have identified appears to 
be the main receptor on endothelial cells for laminin. This 
result does  not agree  with the  recent claim that the en- 
dothelial cell laminin receptor is the larmnin-binding 67-69- 
kD nonintegrin protein previously identified in several other 
cell lines (YannarieUo-Brown et al., 1988). Recent data from 
a number of laboratories have shown that cells other than en- 
dothelial cells have integrin type lamiain receptors, making 
it likely that this would also be the case with endothelial 
cells. Moreover, the sequence of  the 67-69-kD protein is that 
of a typical cytoplasmic protein, in that it has no clearly dis- 
cernible signal sequence or transmembrane sequence (Mak- 
rides et al.,  1988;  Hunt and Barker,  1988).  The evidence 
therefore, strongly favors the integrin as the endothelial cell 
laminin receptor. 
The a2/~, integrin we describe here as the laminin recep- 
tor is the fourth laminin-binding integrin described in the 
literature. It is difficult  to see why so many different  receptors 
would be needed for laminin. There is redundancy in the 
integrin system such that a  single matrix protein can have 
more  than  one  receptor.  This  is  best  documented  with 
fibronectin which hinds at least to the as/~ and gp Ilb/lIIa 
integrins (Pytela et al., 1986), the integrin studied here, and 
possibly by others (Geblsen et al.,  1988;  Cheresh et al., 
1989). Laminin may have more than one cell attachment site 
(reviewed in Tunpl, 1989) and some receptor heterogeneity 
may, therefore, be needed to provide receptors for such alter- 
native sites. However, recent evidence shows that laminin is 
not a single protein but a mixture of proteins with shared and 
unioue subunits and tissue-specific distributions (Hunter et 
al., 1989; Ehrig et al., 1989). It is an exciting possibility that 
the various laminin-binding integrins might recognize only 
one form of laminin each, and that this would endow a cell 
with the ability to recognize the appropriate basement mem- 
branes. 
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